Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.6 USD | -2.12% |
|
-10.34% | -13.21% |
May. 15 | HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating | MT |
May. 14 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.21% | 386M | |
+40.80% | 53.67B | |
-8.05% | 38.76B | |
+35.79% | 38.86B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing